FOXP3 and lung carcinoma: The expression of FOXP3/CD3 increased with the progression of lung cancer pathological staging, with mean values of 0.46 ± 0.35 in stage I, 0.26 ± 0.13 in stage II, and 0.48 ± 0.26 in stage III (Figure 2C).